Helios, a workers’ compensation pharmacy-benefit manager, has been purchased by UnitedHealth Group subsidiary OptumRx, both companies confirmed on Tuesday.
Terms of the acquisition were not disclosed, but analysts have estimated the deal to be in the $1.5 billion range. Helios had been owned by private equity owners, Kelso & Co. and Stone Point Capital.
Sarah Berger, Helios’ vice president of marketing, said the acquisition became official on Jan. 15. The “expertise and breadth of the OptumRx organization” will allow Helios to better serve its clients, she said.
...
Comments